Cancer Immunology Overview

A developing hub for unpacking cancer-immunology research summaries, discussing treatment experiences, applying context and community support.

This is the main hub for cancer-immunology topics on the site.

Use it to explore immune biology, treatment research, patient advocacy, and resources as they are added.

Immunology vs immunotherapy

• Immunology is the broad study of the immune system: how immune cells recognise danger, maintain tolerance, and interact with tissues, infections, autoimmunity, and cancer.
• Cancer immunology focuses specifically on the dynamic interaction between the immune system and tumours, including surveillance, escape mechanisms, and the tumour-immune microenvironment.
• Immunotherapy sits inside this bigger space: it’s any treatment that harnesses or modulates the immune system to treat disease, including cancer, allergies, autoimmune disease, infections, and more

Pages in this hub

• What Is Cancer Immunotherapy? Learn how immunotherapy helps the immune system recognise or attack cancer. Explore checkpoint inhibitors, CAR-T, vaccines, cell therapies, and bi-specific antibodies. Learn some basics about the cancer immunity cylcle. Understand why results differ between tumour types, how “hot” and “cold” tumours affect treatment, what biomarkers may matter, and which safety and evidence questions to raise with a clinical team.
• T Cells in Cancer: A Patient Overview T cells help the immune system recognise cancer, coordinate a response, and limit harmful inflammation. Understanding their different roles can make immunotherapy terms easier to follow. It also helps you ask clearer questions about treatment goals, biomarkers, side effects, and the limits of early research.
• Gamma–delta T cells in cancer: a 2026 research review Explore a T-cell type that can sense stressed cancer cells differently from conventional T cells. This review explains why gamma–delta therapies may help in difficult cancers, what researchers are testing in trials, and why promising early findings do not yet make these treatments standard care.

Find the context for your question

What treatment questions does immunotherapy raise?

Start with What Is Cancer Immunotherapy?. It explains treatment types, evidence, benefits, and risks.

Use these guides when you need a specific answer:

• Where immunotherapy works well and where it struggles explains why cancer type and setting matter.
• The cancer-immunity cycle shows where an immune response can break down.
• Hot and cold tumours explains why T cells may not reach every tumour.
• Why responses differ covers biomarkers, immune context, and prior treatment.
• Questions for a clinic or treatment team helps prepare for appointments.

What shapes the immune context?

The immune environment includes cells, tumour signals, inflammation, and tissue access. It can influence whether immunotherapy has a realistic chance to work.

• T Cells in Cancer: A Patient Overview explains cells that immunotherapies try to activate or direct.
• Macrophages in Cancer covers immune cells that may support or suppress anti-tumour responses.
• Diet and Gut Health May Shape Immunotherapy Response explores emerging gut, T-cell metabolism, and checkpoint-response research.

Keep evidence and safety in view

A strong rationale does not guarantee personal benefit. Check evidence for the exact treatment and cancer setting.

• Understanding evidence levels separates early research from established care.
• Safety and immune-related side effects covers risks needing prompt clinical attention.
• Testing, Monitoring & Biomarkers Overview connects treatment discussions with testing and monitoring questions.

This information is for education only. It is not medical advice, diagnosis, or treatment. Please speak with a qualified clinician before making changes to care, medication, or supplement use.

© 2026 Abbey Mitchell. All rights reserved. Please share by URL rather than copying page text.